Chemoproteomics profiling of HDAC inhibitors reveals selective targeting of HDAC complexes

Cited by (684)

Items 101–200 of 684

1. Mechanistic and Structural Features of PROTAC Ternary Complexes
   Ryan Casement, Adam G. Bond, Conner Craigon, Alessio Ciulli · 2021 · Methods in molecular biology
2. In Vivo Imaging of Histone Deacetylases (HDACs) in the Central Nervous System and Major Peripheral Organs
   Changning Wang, Frederick A. Schroeder, Hsiao‐Ying Wey, Ronald Borra, Florence F. Wagner, Surya A. Reis, Sung Won Kim, Edward B. Holson, Stephen J. Haggarty, Jacob M. Hooker · 2014 · Journal of Medicinal Chemistry
3. ERG and FLI1 binding sites demarcate targets for aberrant epigenetic regulation by AML1-ETO in acute myeloid leukemia
   Joost H.A. Martens, Amit Mandoli, Femke Simmer, Bart‐Jan Wierenga, Sadia Saeed, Abhishek A. Singh, Lucia Altucci, Edo Vellenga, Hendrik G. Stunnenberg · 2012 · Blood
4. A Novel Class of Small Molecule Inhibitors of HDAC6
   Elizabeth S. Inks, Benjamin John Josey, Sean R. Jesinkey, C. James Chou · 2011 · ACS Chemical Biology
5. An evolving understanding of nuclear receptor coregulator proteins
   Christopher J. Millard, Peter J. Watson, Louise Fairall, John W. R. Schwabe · 2013 · Journal of Molecular Endocrinology
6. Chemoproteomic approaches to drug target identification and drug profiling
   Marcus Bantscheff, Gerard Drewes · 2011 · Bioorganic & Medicinal Chemistry
7. Know your target, know your molecule
   Mark E. Bunnage, Adam M. Gilbert, Lyn H. Jones, Erik C. Hett · 2015 · Nature Chemical Biology
8. Functional dissection of lysine deacetylases reveals that HDAC1 and p300 regulate AMPK
   Yu-Yi Lin, Samara Flamini Kiihl, Yasir Suhail, Shang‐Yun Liu, Yi‐Hsuan Chou, Zheng Kuang, Jin‐Ying Lu, Chin Ni Khor, Chi-Long Lin, Joel S. Bader et al. · 2012 · Nature · Retracted
9. Probing the role of HDACs and mechanisms of chromatin-mediated neuroplasticity
   Stephen J. Haggarty, Li‐Huei Tsai · 2011 · Neurobiology of Learning and Memory
10. Epigenetics of Peripheral B-Cell Differentiation and the Antibody Response
    Hong Zan, Paolo Casali · 2015 · Frontiers in Immunology
11. Selective Inhibition of Histone Deacetylase 10: Hydrogen Bonding to the Gatekeeper Residue is Implicated
    Magalie N. E. Géraldy, Michael Morgen, Peter A. Sehr, Raphael R. Steimbach, Davide Moi, Johannes Ridinger, Ina Oehme, Olaf Witt, Mona Malz, Mauro S. Nogueira et al. · 2019 · Journal of Medicinal Chemistry
12. Understanding resistance to combination chemotherapy
    Justin R. Pritchard, Douglas A. Lauffenburger, Michael T. Hemann · 2012 · Drug Resistance Updates
13. Suberoylanilide Hydroxamic Acid Treatment Reveals Crosstalks among Proteome, Ubiquitylome and Acetylome in Non-Small Cell Lung Cancer A549 Cell Line
    Quan Wu, Zhongyi Cheng, Jun Zhu, Weiqing Xu, Xiaojun Peng, Chuangbin Chen, Wenting Li, Fengsong Wang, Lejie Cao, Xingling Yi et al. · 2015 · Scientific Reports
14. Transcription and beyond: the role of mammalian class I lysine deacetylases
    Mirjam Andrea Moser, Astrid Hagelkrüys, Christian Seiser · 2013 · Chromosoma
15. Identification of KasA as the cellular target of an anti-tubercular scaffold
    Katherine A. Abrahams, Chun‐wa Chung, Sonja Ghidelli, Joaquín Rullás, María José Rebollo-López, Sudagar S. Gurcha, Jonathan A. G. Cox, Alfonso Mendoza-Losana, Elena Jiménez‐Navarro, Maria Santos Martínez et al. · 2016 · Nature Communications
16. Affinity Profiling of the Cellular Kinome for the Nucleotide Cofactors ATP, ADP, and GTP
    Isabelle Becher, Mikhail M. Savitski, Maria Fälth Savitski, Carsten Hopf, Marcus Bantscheff, Gerard Drewes · 2012 · ACS Chemical Biology
17. Towards Selective Inhibition of Histone Deacetylase Isoforms: What Has Been Achieved, Where We Are and What Will Be Next
    Florian Thaler, Ciro Mercurio · 2013 · ChemMedChem
18. Light-controlled modulation of gene expression by chemical optoepigenetic probes
    Surya A. Reis, Balaram Ghosh, J. Adam Hendricks, D. Miklos Szantai‐Kis, Lisa Toerk, Kenneth N. Ross, Justin Lamb, Willis Read-Button, Baixue Zheng, Hongtao Wang et al. · 2016 · Nature Chemical Biology
19. Preclinical Investigation of the Novel Histone Deacetylase Inhibitor AR-42 in the Treatment of Cancer-Induced Cachexia
    Yu‐Chou Tseng, Samuel Kiyota Kulp, I‐Lu Lai, En‐Chi Hsu, Wei He, David Eugene Frankhouser, Pearlly S. Yan, Xiaokui Molly Mo, Mark Bloomston, Gregory B. Lesinski et al. · 2015 · JNCI Journal of the National Cancer Institute
20. The Transcription Factor Sp3 Cooperates with HDAC2 to Regulate Synaptic Function and Plasticity in Neurons
    Hidekuni Yamakawa, Jemmie Cheng, Jay Penney, Fan Gao, Richard Rueda, Jun Wang, Satoko Yamakawa, Oleg Kritskiy, Elizabeta Gjoneska, Li‐Huei Tsai · 2017 · Cell Reports
21. Post-translational Modifications Regulate Class IIa Histone Deacetylase (HDAC) Function in Health and Disease
    Mathias, Rommel A., Guise, Amanda J., Cristea, Ileana M. · 2015 · Molecular & Cellular Proteomics
22. Essential but Not Vulnerable: Indazole Sulfonamides Targeting Inosine Monophosphate Dehydrogenase as Potential Leads againstMycobacterium tuberculosis
    Yumi Park, Angela Pacitto, Tracy Bayliss, Laura A. T. Cleghorn, Zhe Wang, Travis E. Hartman, Kriti Arora, Thomas R. Ioerger, J.C. Sacchettini, Menico Rizzi et al. · 2016 · ACS Infectious Diseases
23. A chemical probe toolbox for dissecting the cancer epigenome
    Jake Shortt, Christopher J. Ott, Ricky W. Johnstone, James E. Bradner · 2017 · Nature reviews. Cancer
24. Manipulation of B-cell responses with histone deacetylase inhibitors
    Michaela Waibel, Ailsa J. Christiansen, Margaret L. Hibbs, Jake Shortt, Sarah A. Jones, Ian J. Simpson, Amanda Light, Kristy O’Donnell, Eric Francis Morand, David Mathew Tarlinton et al. · 2015 · Nature Communications
25. HDAC4 Controls Muscle Homeostasis through Deacetylation of Myosin Heavy Chain, PGC-1α, and Hsc70
    Liqing Luo, Sherry C. Martin, Jascha D. Parkington, Samuel M. Cadena, Jiang Zhu, Chikwendu Ibebunjo, Serge Summermatter, Nicole Londraville, Krystyna Patora‐Komisarska, Leo Widler et al. · 2019 · Cell Reports
26. Chemo-proteomics exploration of HDAC degradability by small molecule degraders
    Yuan Xiong, Katherine A. Donovan, Nicholas A. Eleuteri, Nadia Kirmani, Hong Yue, Anthony Razov, Noah M. Krupnick, Radosław P. Nowak, Eric S. Fischer · 2021 · Cell chemical biology
27. Inhibition of Resistance-Refractory P. falciparum Kinase PKG Delivers Prophylactic, Blood Stage, and Transmission-Blocking Antiplasmodial Activity
    Manu Vanaerschot, James M. Murithi, Charisse Flerida A. Pasaje, Sonja Ghidelli, Louis Dwomoh, Megan J. Bird, Natasha Spottiswoode, Nimisha Mittal, Lauren B. Coulson, Edward S. Owen et al. · 2020 · Cell chemical biology
28. Structure-Based Optimization of Naphthyridones into Potent ATAD2 Bromodomain Inhibitors
    Paul Bamborough, Chun‐wa Chung, Rebecca C. Furze, Paola Grandi, Anne‐Marie Michon, Robert J. Sheppard, Heather Barnett, Hawa Diallo, David P. Dixon, Clement Douault et al. · 2015 · Journal of Medicinal Chemistry
29. A Modular Probe Strategy for Drug Localization, Target Identification and Target Occupancy Measurement on Single Cell Level
    Anna Rutkowska, Douglas W. Thomson, Johanna Vappiani, Thilo Werner, Katrin M. Mueller, Lars Dittus, Jana Krause, Marcel Muelbaier, Giovanna Bergamini, Marcus Bantscheff · 2016 · ACS Chemical Biology
30. Inhibitors of DNA Methylation, Histone Deacetylation, and Histone Demethylation
    Cynthia A. Zahnow, Michael J. Topper, Meredith L. Stone, Tracy Murray Stewart, H. Li, Stephen B. Baylin, Robert A. Casero · 2016 · Advances in cancer research
31. Histone deacetylase inhibitors for cancer therapy: An evolutionarily ancient resistance response may explain their limited success
    John A. Halsall, Bryan M. Turner · 2016 · BioEssays
32. 3,3′-Diindolylmethane, but not indole-3-carbinol, inhibits histone deacetylase activity in prostate cancer cells
    Laura M. Beaver, Tianwei Yu, Elizabeth I. Sokolowski, David E. Williams, Roderick H. Dashwood, Emily Ho · 2012 · Toxicology and Applied Pharmacology
33. Selective Inhibition of HDAC1 and HDAC2 as a Potential Therapeutic Option for B-ALL
    Matthew C. Stubbs, Wonil Kim, Megan A. Bariteau, Tina N. Davis, S. Vempati, J. Minehart, M. Witkin, J. Qi, A. Krivtsov, J. Bradner et al. · 2015 · Clinical Cancer Research
34. Epigenetic reader complexes of the human malaria parasite, Plasmodium falciparum
    Wieteke A. M. Hoeijmakers, Jun Miao, Sabine Schmidt, Christa Geeke Toenhake, Sony Shrestha, Jeron Venhuizen, Rob Henderson, Jakob Birnbaum, Sonja Ghidelli, Gerard Drewes et al. · 2019 · Nucleic Acids Research
35. Class IIa HDAC inhibition enhances ER stress-mediated cell death in multiple myeloma
    Shohei Kikuchi, Rikio Suzuki, Hiroto Ohguchi, Y Yoshida, D Lu, Francesca Cottini, Jana Jakubı́ková, Giada Bianchi, Takeshi Harada, Güllü Görgün et al. · 2015 · Leukemia
36. Global profiling of protein–DNA and protein–nucleosome binding affinities using quantitative mass spectrometry
    Matthew M. Makowski, Cathrin Gräwe, Benjamin M. Foster, Nhuong V. Nguyen, Till Bartke, Michiel Vermeulen · 2018 · Nature Communications
37. Phytochemicals from Cruciferous Vegetables, Epigenetics, and Prostate Cancer Prevention
    Gregory W. Watson, Laura M. Beaver, David E. Williams, Roderick H. Dashwood, Emily Ho · 2013 · The AAPS Journal
38. Engineering Genetic Predisposition in Human Neuroepithelial Stem Cells Recapitulates Medulloblastoma Tumorigenesis
    Miller Huang, Jignesh K. Tailor, Qiqi Zhen, Aaron H. Gillmor, Matthew Lee Miller, Holger Weishaupt, Justin Chen, Tina Zheng, Emily K. Nash, Lauren K. McHenry et al. · 2019 · Cell stem cell
39. Overexpressed HDAC8 in cervical cancer cells shows functional redundancy of tubulin deacetylation with HDAC6
    G.R. Vanaja, Hemalatha Golaconda Ramulu, Arunasree Marasanapalli Kalle · 2018 · Cell Communication and Signaling
40. HDAC Family Members Intertwined in the Regulation of Autophagy: A Druggable Vulnerability in Aggressive Tumor Entities
    Emily Koeneke, Olaf Witt, Ina Oehme · 2015 · Cells
41. Chromatin acetylation at transcription start sites and vitamin D receptor binding regions relates to effects of 1α,25-dihydroxyvitamin D3 and histone deacetylase inhibitors on gene expression
    Sabine Seuter, Sami Heikkinen, Carsten Carlberg · 2012 · Nucleic Acids Research
42. Affinity-based target identification for bioactive small molecules
    Makoto Kawatani, Hiroyuki Osada · 2013 · MedChemComm
43. Disruption of the Class IIa HDAC Corepressor Complex Increases Energy Expenditure and Lipid Oxidation
    Vidhi Gaur, Timothy Connor, Andrew J. Sanigorski, Sheree D. Martin, Clinton R. Bruce, Darren C. Henstridge, Simon T. Bond, Kevin A. McEwen, Lyndal Kerr-Bayles, Trent D. Ashton et al. · 2016 · Cell Reports
44. Mechanism of Action for HDAC Inhibitors—Insights from Omics Approaches
    Wenbo Li, Zheng Sun · 2019 · International Journal of Molecular Sciences
45. Histone deacetylases as targets for the treatment of neurodegenerative disorders: Challenges and future opportunities
    Daniel Alencar Rodrigues, Pedro de Sena Murteira Pinheiro, Fernanda Savacini Sagrillo, María Laura Bolognesi, Carlos Alberto Manssour Fraga · 2020 · Medicinal Research Reviews
46. Application guide for omics approaches to cell signaling
    Zhong Yao, Julia Petschnigg, Robin Ketteler, Igor Štagljar · 2015 · Nature Chemical Biology
47. The structure based design of dual HDAC/BET inhibitors as novel epigenetic probes
    Stephen J. Atkinson, Peter E. Soden, Davina C. Angell, Marcus Bantscheff, Chun‐wa Chung, Kathryn A. Giblin, Nicholas N. Smithers, Rebecca C. Furze, Laurie J. Gordon, Gerard Drewes et al. · 2014 · MedChemComm
48. Deep brain stimulation, histone deacetylase inhibitors and glutamatergic drugs rescue resistance to fear extinction in a genetic mouse model
    Nigel Whittle, Claudia Schmuckermair, Ozge Gunduz‐Cinar, Markus Hauschild, Francesco Ferraguti, Andrew Holmes, Nicolas Singewald · 2012 · Neuropharmacology
49. Emerging approaches for histone deacetylase inhibitor drug discovery
    Clemens Zwergel, Sérgio Valente, Claus Jacob, Antonello Mai · 2015 · Expert Opinion on Drug Discovery
50. Structural basis for the design and synthesis of selective HDAC inhibitors
    Simone Di Micco, Maria Giovanna Chini, Stefania Terracciano, Ines Bruno, Raffaele Riccio, Giuseppe Bifulco · 2013 · Bioorganic & Medicinal Chemistry
51. Absence of autophagy promotes apoptosis by modulating the ROS-dependent RLR signaling pathway in classical swine fever virus-infected cells
    Jingjing Pei, Jieru Deng, Zuodong Ye, Jiaying Wang, Hongchao Gou, Wenjun Liu, Mingqiu Zhao, Ming Liao, Lin Yi, Jinding Chen · 2016 · Autophagy
52. Target identification of small molecules based on chemical biology approaches
    Yushi Futamura, Makoto Muroi, Hiroyuki Osada · 2013 · Molecular BioSystems
53. Diverse nucleosome Site-Selectivity among histone deacetylase complexes
    Zhipeng A. Wang, Christopher J. Millard, Chia‐Liang Lin, Jennifer E. Gurnett, Mingxuan Wu, Kwangwoon Lee, Louise Fairall, John W. R. Schwabe, Philip A. Cole · 2020 · eLife
54. Proteome-wide analysis reveals widespread lysine acetylation of major protein complexes in the malaria parasite
    Simon A. Cobbold, Joana Santos, Alejandro Ochoa, David H. Perlman, Manuel Llinás · 2016 · Scientific Reports
55. Innovative Strategies for Selective Inhibition of Histone Deacetylases
    Maolanon, Alex R., Madsen, Andreas S., Olsen, Christian A. · 2016 · Cell Chemical Biology
56. Histone deacetylase 2 selective inhibitors: A versatile therapeutic strategy as next generation drug target in cancer therapy
    Manasa Gangadhar Shetty, Padmini Pai, Renita Esther Deaver, Kapaettu Satyamoorthy, Kampa Sundara Babitha · 2021 · Pharmacological Research
57. Histone Deacetylase 10 Regulates the Cell Cycle G2/M Phase Transition via a Novel Let-7–HMGA2–Cyclin A2 Pathway
    Yixuan Li, Lirong Peng, Edward Seto · 2015 · Molecular and Cellular Biology
58. Regulation of Retinoic Acid Inducible Gene-I (RIG-I) Activation by the Histone Deacetylase 6
    Helene Minyi Liu, Fuguo Jiang, Yueh–Ming Loo, Shu‐Chen Hsu, Tien-Ying Hsiang, Joseph Marcotrigiano, Michael Gale · 2016 · EBioMedicine
59. The Histone Deacetylase Family: Structural Features and Application of Combined Computational Methods
    Antonio Curcio, Roberta Rocca, Stefano Alcaro, Anna Artese · 2024 · Pharmaceuticals
60. The differential short- and long-term effects of HIV-1 latency-reversing agents on T cell function
    Genevieve Clutton, Yinyan Xu, Pedro L. Baldoni, Katie R. Mollan, Jennifer Kirchherr, William Newhard, Kara Cox, JoAnn D. Kuruc, Angela D. M. Kashuba, Richard Barnard et al. · 2016 · Scientific Reports
61. Quantifying Target Occupancy of Small Molecules Within Living Cells
    Matthew B. Robers, Rachel Friedman Ohana, K. Huber, Laura E. Kilpatrick, James D. Vasta, Benedict‐Tilman Berger, Charu Chaudhry, Stephen John Hill, Susanne Müller, Stefan Knapp et al. · 2020 · Annual Review of Biochemistry
62. THPP target assignment reveals EchA6 as an essential fatty acid shuttle in mycobacteria
    Jonathan A. G. Cox, Katherine A. Abrahams, Carlos Alemparte, Sonja Ghidelli, Joaquín Rullás, Íñigo Angulo‐Barturen, Albel Singh, Sudagar S. Gurcha, Vijayashankar Nataraj, Stephen Bethell et al. · 2016 · Nature Microbiology
63. An HDAC3-PROX1 corepressor module acts on HNF4α to control hepatic triglycerides
    Armour, Sean M., Remsberg, Jarrett R., Damle, Manashree, Sidoli, Simone, Ho, Wesley Y., Li, Zhenghui, Garcia, Benjamin A., Lazar, Mitchell A. · 2017 · Nature Communications
64. Ca 2+ signals critical for egress and gametogenesis in malaria parasites depend on a multipass membrane protein that interacts with PKG
    Aurélia C. Balestra, Konstantinos Koussis, Natacha Klages, Steven A. Howell, Helen R. Flynn, Marcus Bantscheff, Carla Pasquarello, Abigail J. Perrin, Lorenzo Brusini, Patrizia Arboit et al. · 2021 · Science Advances
65. Drug Target Identification in Tissues by Thermal Proteome Profiling
    André Mateus, Nils Kurzawa, Jessica Perrin, Giovanna Bergamini, Mikhail M. Savitski · 2021 · The Annual Review of Pharmacology and Toxicology
66. Enhancing dopaminergic signaling and histone acetylation promotes long-term rescue of deficient fear extinction
    Nigel Whittle, Verena Maurer, Conor P. Murphy, Johannes Rainer, Daniel Bindreither, Markus Hauschild, Anja Scharinger, M. Oberhauser, Tobias W. M. Keil, Christina Brehm et al. · 2016 · Translational Psychiatry
67. Histone deacetylases (HDACs) as therapeutic target for depressive disorders
    Paulina Misztak, Patrycja Pańczyszyn-Trzewik, Magdalena Sowa-Kućma · 2017 · Pharmacological Reports
68. Recent advances on the encoding and selection methods of DNA-encoded chemical library
    Bingbing Shi, Yu Zhou, Yiran Huang, Jian-Fu Zhang, Xiaoyu Li · 2016 · Bioorganic & Medicinal Chemistry Letters
69. Histone deacetylase complexes: Structure, regulation and function
    Moges Dessale Asmamaw, Ang He, Lirong Zhang, Hong‐Min Liu, Ya Gao · 2024 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
70. Chemoproteomic Profiling of Lysine Acetyltransferases Highlights an Expanded Landscape of Catalytic Acetylation
    David C. Montgomery, Alexander W. Sorum, Jordan L. Meier · 2014 · Journal of the American Chemical Society
71. The Effect of Various Zinc Binding Groups on Inhibition of Histone Deacetylases 1–11
    Andreas S. Madsen, Helle M. E. Kristensen, Gyrithe Lanz, Christian Adam Olsen · 2013 · ChemMedChem
72. Modulation of KDM1A with vafidemstat rescues memory deficit and behavioral alterations
    Tamara Maes, Cristina Mascaró, David Rotllant, Michele MP Lufino, Angels Estiarte, Nathalie Guibourt, Fernando Cavalcanti, Christian Griñán‐Ferré, Mercè Pallàs, Roser A. Nadal et al. · 2020 · PLoS ONE
73. Histone H2B Deacylation Selectivity: Exploring Chromatin’s Dark Matter with an Engineered Sortase
    Zhipeng A. Wang, Samuel D. Whedon, Mingxuan Wu, Siyu Wang, Edward A. Brown, Ananya Anmangandla, Liam Regan, Kwangwoon Lee, Jianfeng Du, Jun Young Hong et al. · 2022 · Journal of the American Chemical Society
74. Chromatin accessibility, p300, and histone acetylation define PML-RARα and AML1-ETO binding sites in acute myeloid leukemia
    Sadia Saeed, Colin Logie, Kees‐Jan Françoijs, Gianmaria Frigè, Mauro Romanenghi, Fiona G. G. Nielsen, Lianne Raats, Maryam Shahhoseini, Martijn A. Huynen, Lucia Altucci et al. · 2012 · Blood
75. Label-Free in Situ Monitoring of Histone Deacetylase Drug Target Engagement by Matrix-Assisted Laser Desorption Ionization-Mass Spectrometry Biotyping and Imaging
    Bogdan Munteanu, Björn Meyer, Carolina Reitzenstein, Elke Burgermeister, Susanne Bog, Andreas Martin Pahl, Matthias Ebert, Carsten Hopf · 2014 · Analytical Chemistry
76. Targeting class I histone deacetylases in cancer therapy
    Geneviève P. Delcuve, Dilshad H. Khan, James Davie · 2012 · Expert Opinion on Therapeutic Targets
77. Lysine-14 acetylation of histone H3 in chromatin confers resistance to the deacetylase and demethylase activities of an epigenetic silencing complex
    Mingxuan Wu, Dawn Hayward, Jay H. Kalin, Yun Song, John W. R. Schwabe, Philip A. Cole · 2018 · eLife
78. Sin3a-associated Hdac1 and Hdac2 are essential for hematopoietic stem cell homeostasis and contribute differentially to hematopoiesis
    Marinus R. Heideman, Cesare Lancini, Natalie Proost, Eva Yanover, Heinz Jacobs, J.-H. Dannenberg · 2014 · Haematologica
79. Structure-Based Inhibitor Discovery of Class I Histone Deacetylases (HDACs)
    Luo, Yuxiang, Li, Huilin · 2020 · International Journal of Molecular Sciences
80. A Pan-Histone Deacetylase Inhibitor Enhances the Antitumor Activity of B7-H3–Specific CAR T Cells in Solid Tumors
    Xinyuan Lei, Zhanpeng Ou, Zhao‐hui Yang, Jianglong Zhong, Yanliang Zhu, Jing Tian, Jiannan Wu, Heran Deng, Xinyu Lin, Peng Yu et al. · 2021 · Clinical Cancer Research
81. Image-Guided Synthesis Reveals Potent Blood-Brain Barrier Permeable Histone Deacetylase Inhibitors
    Young Jun Seo, Yeona Kang, Lisa Muench, Alicia E. Reid, Shannon Caesar, Logan Jean, Florence F. Wagner, Edward B. Holson, Stephen J. Haggarty, Philipp Weiss et al. · 2014 · ACS Chemical Neuroscience
82. Identification of a Novel Aminotetralin Class of HDAC6 and HDAC8 Selective Inhibitors
    Guozhi Tang, Jason C. Wong, Weixing Zhang, Zhanguo Wang, Nan Zhang, Zhenghong Peng, Zhenshan Zhang, Yiping Rong, Shijie Li, Meifang Zhang et al. · 2014 · Journal of Medicinal Chemistry
83. Targeting the epigenome for treatment of cancer
    E-J Geutjes, Prashanth Kumar Bajpe, René Bernards · 2011 · Oncogene
84. Discovery of an orally active subtype-selective HDAC inhibitor, chidamide, as an epigenetic modulator for cancer treatment
    Desi Pan, Qian‐Jiao Yang, Xin Fu, Song Shan, Jing-Zhong Zhu, Kun Zhang, Zhibin Li, Zhiqiang Ning, Xianping Lu · 2014 · MedChemComm
85. Structural and functional characterization of a cell cycle associated HDAC1/2 complex reveals the structural basis for complex assembly and nucleosome targeting
    Toshimasa Itoh, Louise Fairall, Frederick W. Muskett, Charles P. Milano, Peter J. Watson, Nadia Arnaudo, Almutasem Saleh, Christopher J. Millard, Mohammed El‐Mezgueldi, Fabrizio Martino et al. · 2015 · Nucleic Acids Research
86. A Proteomic Approach to Analyze the Aspirin-mediated Lysine Acetylome
    Michael H. Tatham, Christian Cole, Paul Scullion, Ross P. Wilkie, Nicholas James Westwood, Lesley A. Stark, Ronald T. Hay · 2016 · Molecular & Cellular Proteomics
87. RNA-dependent dynamic histone acetylation regulates MCL1 alternative splicing
    Dilshad H. Khan, Carolina Gonzalez, Charlton Cooper, Jian-Min Sun, Hou Yu Chen, Shannon Healy, Wayne Wenzhong Xu, Karen T. Smith, Jerry L. Workman, Etienne Leygue et al. · 2013 · Nucleic Acids Research
88. Functional-genetic dissection of HDAC dependencies in mouse lymphoid and myeloid malignancies
    Geoffrey M. Matthews, Parinaz Mehdipour, Leonie A. Cluse, Katrina J. Falkenberg, Eric Wang, Mareike Roth, Fabio Santoro, Eva Vidacs, Kym L. Stanley, Colin M. House et al. · 2015 · Blood
89. Chemoproteomics Reveals Time-Dependent Binding of Histone Deacetylase Inhibitors to Endogenous Repressor Complexes
    Becher, Isabelle, Dittmann, Antje, Savitski, Mikhail M., Hopf, Carsten, Drewes, Gerard, Bantscheff, Marcus · 2014 · ACS Chemical Biology
90. Three-dimensional tumor cell growth stimulates autophagic flux and recapitulates chemotherapy resistance
    Corinna Bingel, Emily Koeneke, Johannes Ridinger, Annika Bittmann, Martin Sill, Heike Peterziel, Jagoda K. Wrobel, I Rettig, Till Milde, Uta Fernekorn et al. · 2017 · Cell Death and Disease
91. Histone Deacetylase Classes I and II Regulate Kaposi's Sarcoma-Associated Herpesvirus Reactivation
    Hye Jin Shin, Jennifer DeCotiis, Mario Giron, Diana Palmeri, David M. Lukac · 2013 · Journal of Virology
92. Notch signaling functions in lymphatic valve formation
    Murtomaki, Aino, Uh, Minji K., Kitajewski, Chris, Zhao, Jin, Nagasaki, Takayuki, Shawber, Carrie J., Kitajewski, Jan · 2014 · Development
93. Lessons in Organic Fluorescent Probe Discovery
    Sachin Bhausaheb Wagh, Vladimir A. Maslivetc, James J. La Clair, Alexander Kornienko · 2021 · ChemBioChem
94. Selective class IIa HDAC inhibitors: myth or reality
    Eros Di Giorgio, Enrico Gagliostro, Claudio Brancolini · 2014 · Cellular and Molecular Life Sciences
95. Toxicological and metabolic considerations for histone deacetylase inhibitors
    Joanna Fraczek, Tamara Vanhaecke, Vera Rogiers · 2013 · Expert Opinion on Drug Metabolism & Toxicology
96. Histone modifications and a choice of variant: a language that helps the genome express itself
    Zachary A. Gurard‐Levin, Geneviève Almouzni · 2014 · F1000Prime Reports
97. Evaluation of the Therapeutic Potential of the Novel Isotype Specific HDAC Inhibitor 4SC-202 in Urothelial Carcinoma Cell Lines
    Maria Pinkerneil, Michèle J. Hoffmann, Hella Kohlhof, Wolfgang A. Schulz, Günter Niegisch · 2016 · Targeted Oncology
98. Human Family with Sequence Similarity 60 Member A (FAM60A) Protein: a New Subunit of the Sin3 Deacetylase Complex
    Karen T. Smith, Mihaela E. Sardiu, Skylar Martin‐Brown, Chris W. Seidel, Arcady R. Mushegian, Rhonda Egidy, Laurence A. Florens, Michael P. Washburn, Jerry L. Workman · 2012 · Molecular & Cellular Proteomics
99. Gene expression-based prediction of myeloma cell sensitivity to histone deacetylase inhibitors
    Jérôme Moreaux, Thierry X. Reme, Wim Leonard, Jean Luc Veyrune, Guilhem Requirand, Hartmut Goldschmidt, Dirk Hose, Bernard Klein · 2013 · British Journal of Cancer
100. Biochemical Screening of Five Protein Kinases from Plasmodium falciparum against 14,000 Cell-Active Compounds
     Gregory J. Crowther, Heidi K. Hillesland, Katelyn R. Keyloun, Molly C. Reid, María José Lafuente-Monasterio, Sonja Ghidelli, Stephen E. Leonard, Panqing He, Jackson C. Jones, Mallory M. Krahn et al. · 2016 · PLoS ONE